Nanyeong Go

In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy

Seokjoong Kim, Jun Chang, Hyukjin Lee, 2022, Science advances.